相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Engineered Nanoparticle Applications for Recombinant Influenza Vaccines
Zachary R. Sia et al.
MOLECULAR PHARMACEUTICS (2021)
Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association
Jasmin Federizon et al.
PHARMACEUTICS (2021)
Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity
Mai N. Vu et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Quadrivalent influenza nanoparticle vaccines induce broad protection
Seyhan Boyoglu-Barnum et al.
NATURE (2021)
Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes
Jasmin Federizon et al.
VACCINE (2020)
An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice
Shuai Shao et al.
ANNALS OF BIOMEDICAL ENGINEERING (2020)
Immunagenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I. Bernstein et al.
LANCET INFECTIOUS DISEASES (2020)
SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination
Wei-Chiao Huang et al.
ADVANCED MATERIALS (2020)
Immunological basis for enhanced immunity of nanoparticle vaccines
Hannah G. Kelly et al.
EXPERT REVIEW OF VACCINES (2019)
Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018
Patricia A. Jorquera et al.
SCIENTIFIC REPORTS (2019)
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies
Yao-Qing Chen et al.
CELL (2018)
Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice
Jiong Wang et al.
PLOS ONE (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Adjuvanted influenza vaccines
John S. Tregoning et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
A malaria vaccine adjuvant based on recombinant antigen binding to liposomes
Wei-Chiao Huang et al.
NATURE NANOTECHNOLOGY (2018)
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Arnaud M. Didierlaurent et al.
EXPERT REVIEW OF VACCINES (2017)
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
Seth J. Zost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
Amy Lingel et al.
SCIENTIFIC REPORTS (2017)
Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
Donald M. Carter et al.
JOURNAL OF VIROLOGY (2016)
Self-assembling protein nanoparticles in the design of vaccines
Jacinto Lopez-Sagaseta et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)
Halothane Modulates the Type I Interferon Response to Influenza and Minimizes the Risk of Secondary Bacterial Pneumonia through Maintenance of Neutrophil Recruitment in an Animal Model
Brian A. MacDonald et al.
ANESTHESIOLOGY (2015)
Functionalization of cobalt porphyrin-phospholipid bilayers with his-tagged ligands and antigens
Shuai Shao et al.
NATURE CHEMISTRY (2015)
The potential of nanoparticles for the immunization against viral infections
Viktoriya Sokolova et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Bat-derived influenza-like viruses H17N10 and H18N11
Ying Wu et al.
TRENDS IN MICROBIOLOGY (2014)
Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies
Peter H. Goff et al.
PLOS ONE (2013)
Cationic liposomes as adjuvants for influenza hemagglutinin: More than charge alone
Christophe Barnier Quer et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
Rong Hai et al.
JOURNAL OF VIROLOGY (2012)
A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates
Florian Krammer et al.
PLOS ONE (2012)
The mechanism of action of MF59 - An innately attractive adjuvant formulation
D. T. O'Hagan et al.
VACCINE (2012)
Liposomal vaccine delivery systems
Malou Henriksen-Lacey et al.
EXPERT OPINION ON DRUG DELIVERY (2011)
MF59 adjuvant: the best insurance against influenza strain diversity
Derek T. O'Hagan et al.
EXPERT REVIEW OF VACCINES (2011)
Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
Steven J. Gamblin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
John Steel et al.
MBIO (2010)
Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza
John Steel et al.
JOURNAL OF VIROLOGY (2009)
Influenza vaccine: The challenge of antigenic drift
F. Carrat et al.
VACCINE (2007)
Influenza virus pleiomorphy characterized by cryoelectron tomography
Audray Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis
Cynthia A. Bonville et al.
VIROLOGY (2006)
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus
J Stevens et al.
SCIENCE (2004)
分享论文
